Ligand · L0I
L0I · 4-[(2-{4-[(cyclopropylcarbamoyl)amino]-1H-pyrazol-3-yl}-1H-benzimidazol-6-yl)methyl]morpholin-4-ium
L0I, 4-[(2-{4-[(cyclopropylcarbamoyl)amino]-1H-pyrazol-3-yl}-1H-benzimidazol-6-yl)methyl]morpholin-4-ium (C19 H24 N7 O2 +1, 382.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- L0I
- Formula
- C19 H24 N7 O2 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L0I in 2 structures; the first of them:
- 2W1I · Structure determination of Aurora Kinase in complex with inhibitor · L0I A2133 · binds GLN853, LEU855, GLY856, LYS857, VAL863, ALA880, VAL911, MET929 and 7 more
- 2W1I · Structure determination of aurora kinase in complex with inhibitor · L0I A2133 · binds GLN853, LEU855, GLY856, LYS857, VAL863, ALA880, VAL911, MET929 and 7 more
Residues it binds most
LEU 2, GLY 2, TYR 2, VAL 2, ALA 2, GLN 2, GLU 2, LYS 2, MET 2, PRO 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.